These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32095091)

  • 41. In-office screening for age-related hearing and vision loss.
    Abyad A
    Geriatrics; 1997 Jun; 52(6):45-6, 51-4, 57. PubMed ID: 9194790
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Care of Older Adults: Role of Primary Care Physicians in the Treatment of Cataracts and Macular Degeneration.
    Marra KV; Wagley S; Kuperwaser MC; Campo R; Arroyo JG
    J Am Geriatr Soc; 2016 Feb; 64(2):369-77. PubMed ID: 26825587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen City Eye Study.
    Buch H; Vinding T; Nielsen NV
    Ophthalmology; 2001 Dec; 108(12):2347-57. PubMed ID: 11733284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melatonin: Implications for Ocular Disease and Therapeutic Potential.
    Scuderi L; Davinelli S; Iodice CM; Bartollino S; Scapagnini G; Costagliola C; Scuderi G
    Curr Pharm Des; 2019; 25(39):4185-4191. PubMed ID: 31724508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lifestyle strategies for the prevention of vision loss.
    Sharts-Hopko NC
    Holist Nurs Pract; 2010; 24(5):284-91. PubMed ID: 20706090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. OCT and IOP findings in a healthy worker cohort: results from a teleophthalmic study in occupational medicine.
    Grau E; Horn F; Nixdorff U; Michelson G
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2571-2578. PubMed ID: 31489489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Visual Impairment and Major Eye Diseases in Chronic Kidney Disease: The National Health and Nutrition Examination Survey, 2005-2008.
    Zhu Z; Liao H; Wang W; Scheetz J; Zhang J; He M
    Am J Ophthalmol; 2020 May; 213():24-33. PubMed ID: 31945332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationships between Hearing Loss and the Prevalences of Cataract, Glaucoma, Diabetic Retinopathy, and Age-Related Macular Degeneration in Korea.
    Kim JM; Kim SY; Chin HS; Kim HJ; Kim NR; Epidemiologic Survey Committee Of The Korean Ophthalmological Society OBOT
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31336642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role and therapeutic potential of melatonin in age-related ocular diseases.
    Crooke A; Huete-Toral F; Colligris B; Pintor J
    J Pineal Res; 2017 Sep; 63(2):. PubMed ID: 28658514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project.
    VanNewkirk MR; Weih L; McCarty CA; Taylor HR
    Ophthalmology; 2001 May; 108(5):960-7. PubMed ID: 11320028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reducing vision loss in chronic eye disease.
    Fong A; Lee G
    Aust Fam Physician; 2009 Oct; 38(10):774-9. PubMed ID: 19893815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation of reactive oxygen species in the anterior eye segment. Synergistic codrugs of N-acetylcarnosine lubricant eye drops and mitochondria-targeted antioxidant act as a powerful therapeutic platform for the treatment of cataracts and primary open-angle glaucoma.
    Babizhayev MA
    BBA Clin; 2016 Dec; 6():49-68. PubMed ID: 27413694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Evolving Functions of Autophagy in Ocular Health: A Double-edged Sword.
    Chai P; Ni H; Zhang H; Fan X
    Int J Biol Sci; 2016; 12(11):1332-1340. PubMed ID: 27877085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Benefits of micronutrient supplementation for reducing the risk of wet age-related macular disease and diabetic retinopathy: An update.
    Battaglia Parodi M; Brunoro A; Tomasso L; Scuderi G
    Eur J Ophthalmol; 2020 Jul; 30(4):780-794. PubMed ID: 32329358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Causes of visual loss and their risk factors: an incidence summary from the Barbados Eye Studies.
    Leske MC; Wu SY; Nemesure B; Hennis A;
    Rev Panam Salud Publica; 2010 Apr; 27(4):259-67. PubMed ID: 20512228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence estimates for lens changes, macular changes, open-angle glaucoma and diabetic retinopathy.
    Podgor MJ; Leske MC; Ederer F
    Am J Epidemiol; 1983 Aug; 118(2):206-12. PubMed ID: 6881126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER.
    Broman AT; Munoz B; Rodriguez J; Sanchez R; Quigley HA; Klein R; Snyder R; West SK
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3393-8. PubMed ID: 12407148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Eye Disorders and Vision Loss Among U.S. Adults Aged 45 and Over With Diagnosed Diabetes, 2016-2017.
    Cha AE; Villarroel MA; Vahratian A
    NCHS Data Brief; 2019 Jul; (344):1-8. PubMed ID: 31442198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of ocular disease and mortality in a diabetic population.
    Klein R; Klein BE; Moss SE; Cruickshanks KJ
    Arch Ophthalmol; 1999 Nov; 117(11):1487-95. PubMed ID: 10565517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Delivery strategies for treatment of age-related ocular diseases: From a biological understanding to biomaterial solutions.
    Delplace V; Payne S; Shoichet M
    J Control Release; 2015 Dec; 219():652-668. PubMed ID: 26435454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.